Trial Profile
A placebo-controlled, randomized, rising multiple dose study of ADV-1002401 to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics in adult male Type-II diabetic subjects
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 31 Aug 2016
Price :
$35
*
At a glance
- Drugs GKM 001 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 23 Sep 2011 New trial record